
Marshall B. Elam MD
Adult Congenital Heart Disease
Professor of Pharmacology and Medicine, Director, Lipid Metabolism Clinics, VAMC, University of Tennessee Health Science Center College of Medicine
Join to View Full Profile
1030 Jefferson AveMemphis Va Hypertension/Lipid Research Clinic 111qMemphis, TN 38104
Phone+1 901-523-8990
Fax+1 901-448-7206
Dr. Elam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of TennesseeFellowship, Cardiovascular Disease, 1982 - 1985
- University of TennesseeResidency, Internal Medicine, 1979 - 1982
- University of Tennessee Health Science Center College of MedicineClass of 1982
Certifications & Licensure
- TN State Medical License 1981 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 16 citationsInsulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1cQingming Dong, Gipsy Majumdar, Robert N. O'Meally, Robert N. Cole, Marshall B. Elam
Molecular and Cellular Biochemistry. 2020-01-01 - Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.Qingming Dong, Gipsy Majumdar, Robert N O'Meally, Robert N Cole, Marshall B Elam
Molecular and cellular biochemistry. 2019-09-22 - Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.Qingming Dong, Gipsy Majumdar, Robert N O'Meally, Robert N Cole, Marshall B Elam
Molecular and cellular biochemistry. 2019-09-22
Journal Articles
- Trial Designs Rationale and Design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) Study☆Marshall Elam, Aruna D Pradhan, William R Hiatt, ScienceDirect
Grant Support
- Molecular Mechanisms Of Mitigation Of Insulin Induction Of SREBP-1C By N-3 PUFAVeterans Affairs2011–2012
- Regulation Of SREBP-1C Processing By Insulin And Cyclic-AmpNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
- Assessment Of Androgenic Hormones In Patients With Coronary Heart DiseaseNational Center For Research Resources1998–2001
- Atherosclerotic Multifactorial Disease Trial--AdmitNational Center For Research Resources1995–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: